Abstract

PEREZAMADOR-DEL CUETO, Maricruz  and  SARABIA-COLLAZO, Ángel Antonio. Analgesia for breast surgery. Rev. mex. anestesiol. [online]. 2019, vol.42, n.3, pp.209-209.  Epub Sep 13, 2021. ISSN 0484-7903.

Postoperative pain is moderate to severe in the first 24 hours after mastectomy, this pain may not resolve in 10% of surgeries, and may persist until after six months in 53% of patients. Postmastectomy pain syndrome (SDPM), also called intercosto-brachial neuralgia, may persist for months or years, in 20-68% of patients. It begins in the immediate postoperative period, is of moderate intensity and of neuropathic characteristics. The factors associated with this type of pain as well as the type of surgery are: prior neo-adjuvant chemotherapy, tumors in upper quadrants, previous mammary resection, metastatic disease, positive hormonal receptors, management with endocrine therapy, radiotherapy and the degree of malignancy of the tumor. New analgesic strategies in the perioperative have emerged in recent years, such as: the use of gabapentinoids, lidocaine and new regional blocks such as blockade of the erector spinae plane, serratus blockade, BRILMA, PEC1 and PEC2, which are effective strategies in acute pain and that is currently analyzing its long-term impact (full version is available inhttp://www.painoutmexico.com ) .

Keywords : Analgesia in breast surgery; postmastectomy painful syndrome; regional techniques in breast surgery; analgesia in mastectomy.